SCHEMBL21792277

SCHEMBL21792277

C=C(CC[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4[C@](C)(CO)[C@@H](O)CC[C@@]45C[C@@]35CC[C@]12C)C(C)C

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 8/20 0.54
▸ ACLY P53396 2/20 0.52
▸ ACACA Q13085 2/20 0.52
▸ PTPN11 Q06124 1/20 0.48
▸ HSD11B2 P80365 1/20 0.43
▸ ESR2 Q92731 2/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ LMNA P02545 1/20 0.37
▸ POLA1 P09884 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ NR1H3 Q13133 1/20 0.36
▸ PTPN1 P18031 2/20 0.36
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ESR1 P03372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13358790 0.90 ACLY (0.63) HSD11B1ACLYACACAPTPN11HSD11B2
SCHEMBL13801861 0.90 ACLY (0.63) HSD11B1ACLYACACAPTPN11HSD11B2
SCHEMBL982765 0.90 ACLY (0.63) HSD11B1ACLYACACAPTPN11HSD11B2
SCHEMBL1878721 0.90 ACLY (0.63) HSD11B1ACLYACACAPTPN11HSD11B2
SCHEMBL14520017 0.90 ACLY (0.63) HSD11B1ACLYACACAPTPN11HSD11B2
SCHEMBL14047057 0.90 ACLY (0.63) HSD11B1ACLYACACAPTPN11HSD11B2
SCHEMBL12152345 0.90 ACLY (0.63) HSD11B1ACLYACACAPTPN11HSD11B2
SCHEMBL13420256 0.90 ACLY (0.63) HSD11B1ACLYACACAPTPN11HSD11B2
SCHEMBL1878720 0.90 ACLY (0.63) HSD11B1ACLYACACAPTPN11HSD11B2
SCHEMBL11408854 0.90 ACLY (0.63) HSD11B1ACLYACACAPTPN11HSD11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210315960-A1 COMPOSITIONS OF AZADIRACHTA INDICA AND METHODS OF TREATING CANCER SOMAN GIRISH SUDHAKAR (IN) 2021-10-14 — — US disclosed
US-20200069636-A1 PROCESS FOR PREPARATION OF CO2 EXTRACT OF AZADIRACHTA INDICA AND HERBAL COMPOSITIONS THEREOF FOR TREATMENT OF CANCERS NISARGA BIOTECH PRIVATE LIMITED (IN) 2020-03-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200069636-A1 PROCESS FOR PREPARATION OF CO2 EXTRACT OF AZADIRACHTA INDICA AND HERBAL COMPOSITIONS THEREOF FOR TREATMENT OF CANCERS SCO2, SI, CYP1A2 HSD11B1 1578/4885ACLY 380/4885ACACA 1164/4885
US-20210315960-A1 COMPOSITIONS OF AZADIRACHTA INDICA AND METHODS OF TREATING CANCER SCO2, NOC2L, NPM1 HSD11B1 2785/4885ACLY 732/4885ACACA 1750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback